Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $3.58 $6.48 Friday, 10th May 2024 FATE stock ended at $4.08. This is 4.62% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 17.83% from a day low at $3.67 to a day high of $4.33.
90 days $3.58 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
Sep 16, 2016 $2.80 $3.14 $2.80 $2.92 419 500
Sep 15, 2016 $2.72 $2.80 $2.61 $2.79 113 700
Sep 14, 2016 $2.70 $2.75 $2.68 $2.71 90 100
Sep 13, 2016 $2.65 $2.75 $2.61 $2.70 187 600
Sep 12, 2016 $2.76 $2.80 $2.63 $2.70 66 000
Sep 09, 2016 $2.77 $2.83 $2.59 $2.75 168 200
Sep 08, 2016 $2.55 $2.84 $2.55 $2.80 137 700
Sep 07, 2016 $2.61 $2.73 $2.40 $2.55 200 800
Sep 06, 2016 $2.21 $2.51 $2.21 $2.43 64 700
Sep 02, 2016 $2.45 $2.52 $2.35 $2.38 116 100
Sep 01, 2016 $2.58 $2.60 $2.32 $2.45 221 000
Aug 31, 2016 $2.65 $2.66 $2.51 $2.60 80 100
Aug 30, 2016 $2.68 $2.72 $2.63 $2.66 26 600
Aug 29, 2016 $2.65 $2.77 $2.59 $2.70 57 200
Aug 26, 2016 $2.60 $2.67 $2.55 $2.62 70 500
Aug 25, 2016 $2.75 $2.77 $2.50 $2.60 300 900
Aug 24, 2016 $2.82 $2.89 $2.73 $2.77 104 800
Aug 23, 2016 $2.87 $2.96 $2.80 $2.84 67 100
Aug 22, 2016 $2.91 $3.02 $2.79 $2.89 208 900
Aug 19, 2016 $2.93 $3.00 $2.67 $2.92 271 500
Aug 18, 2016 $2.92 $2.99 $2.80 $2.92 471 500
Aug 17, 2016 $2.65 $2.85 $2.53 $2.82 396 800
Aug 16, 2016 $2.75 $2.75 $2.58 $2.67 152 700
Aug 15, 2016 $2.57 $2.76 $2.40 $2.73 241 600
Aug 12, 2016 $2.38 $2.69 $2.36 $2.56 357 800
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT